Karen Bush
Member of the Scientific Advisory Board
Management
Allecra
Spain
Biography
Professor Bush received her PhD in Biochemistry from Indiana University and then spent 35 years in the pharmaceutical industry, leading drug discovery and development teams in anti-infective research. She was on the team that discovered aztreonam and participated actively on development teams for piperacillin-tazobactam, levofloxacin, doripenem and ceftobiprole. During that time she was employed by Squibb (Bristol-Myers Squibb), Lederle (Wyeth) and Johnson & Johnson. She is a Fellow of the American Society for Microbiology, was a member of the ICAAC Planning Committee for 8 years, and served as an Editor for Antimicrobial Agents and Chemotherapy for ten years. Professor Bush has published over 200 primary publications, most of which are related to antibiotic drug discovery and resistance, particularly related to beta-lactams. She is currently a Professor of Practice in the Biotechnology program at Indiana University Bloomington where she continues research on beta-lactamases and new drug testing.
Research Interest
Biochemistry
